Drugs / CP-741,952
last change Apr 2007 re-read 3 minutes ago

CP-741,952

Developed for
obesity disorder
Investigated by
Pfizer

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00367783 Jun 2006 → Apr 2007 obesity disorder Pfizer Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CP-741,952 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00367783 ↗